(0.65%) 5 161.28 points
(0.29%) 38 787 points
(0.69%) 16 267 points
(0.12%) $78.20
(4.20%) $2.23
(1.06%) $2 333.10
(3.43%) $27.61
(-0.03%) $965.05
(-0.07%) $0.928
(-0.43%) $10.83
(-0.16%) $0.796
(-0.10%) $91.36
2 days till quarter result
(bmo 2024-05-08)
Expected move: +/- 4.64%
-5.12% INR 112.95
Live Chart Being Loaded With Signals
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches...
Stats | |
---|---|
Объем за сегодня | 576 113 |
Средний объем | 677 784 |
Рыночная капитализация | 11.82B |
EPS | INR0 ( 2024-01-22 ) |
Дата следующего отчета о доходах | ( INR0 ) 2024-05-08 |
Last Dividend | INR0.500 ( 2023-07-12 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 13.61 |
ATR14 | INR0.129 (0.11%) |
Объем Корреляция
Bliss GVS Pharma Limited Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Bliss GVS Pharma Limited Корреляция - Валюта/Сырье
Bliss GVS Pharma Limited Финансовые показатели
Annual | 2022 |
Выручка: | INR7.52B |
Валовая прибыль: | INR3.50B (46.60 %) |
EPS: | INR6.83 |
FY | 2022 |
Выручка: | INR7.52B |
Валовая прибыль: | INR3.50B (46.60 %) |
EPS: | INR6.83 |
FY | 2022 |
Выручка: | INR7.38B |
Валовая прибыль: | INR3.47B (47.02 %) |
EPS: | INR2.24 |
FY | 2021 |
Выручка: | INR5.69B |
Валовая прибыль: | INR2.40B (42.16 %) |
EPS: | INR6.64 |
Financial Reports:
No articles found.
Bliss GVS Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0.500 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.300 | 2010-11-25 |
Last Dividend | INR0.500 | 2023-07-12 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | INR9.35 | -- |
Avg. Dividend % Per Year | 0.46% | -- |
Score | 2.16 | -- |
Div. Sustainability Score | 4.34 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 4.30 | -- |
Year | Amount | Yield |
---|---|---|
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.48% |
2019 | INR1.000 | 0.61% |
2020 | INR0.500 | 0.34% |
2021 | INR1.000 | 0.49% |
2022 | INR1.000 | 0.96% |
2023 | INR0.500 | 0.69% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SPAL.NS | Dividend Junior | 2023-09-15 | Sporadic | 8 | 0.44% | |
MOTHERSON.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 0.63% | |
HERITGFOOD.NS | Dividend Junior | 2023-08-14 | Annually | 23 | 0.44% | |
BIKAJI.NS | Dividend Junior | 2023-06-08 | Insufficient data to determine frequency | 2 | 0.06% | |
RANEHOLDIN.NS | Dividend Junior | 2023-07-27 | Annually | 21 | 0.95% | |
KOPRAN.NS | Dividend Junior | 2023-09-07 | Annually | 5 | 1.18% | |
ESCORTS.NS | Dividend Junior | 2023-06-30 | Annually | 28 | 0.21% | |
ALPHAGEO.NS | Dividend Junior | 2023-09-22 | Annually | 18 | 2.07% | |
SYMPHONY.NS | Dividend Knight | 2023-08-04 | Semi-Annually | 14 | 0.47% | |
NESCO.NS | Dividend Junior | 2023-07-28 | Annually | 17 | 0.40% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.116 | 1.500 | 7.68 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.129 | 1.500 | 9.68 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 12.33 | 1.000 | 6.54 | 6.54 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.70 | 2.00 | 8.65 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.477 | 1.000 | 5.38 | 5.38 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.165 | 1.000 | 8.69 | 8.69 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 4.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.65 | 1.000 | 8.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.129 | 2.50 | 9.79 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.436 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.70 | 2.00 | 9.10 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0371 | 1.500 | -3.09 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0373 | 1.000 | -1.566 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
Bliss GVS Pharma Limited
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа